首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

2075928

勃起功能障礙治療市場：按藥物、給藥途徑、分銷管道和地區分類

Erectile Dysfunction Treatment Market, By Drugs, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2026年04月28日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，到2026年，勃起功能障礙治療市場規模將達到56.7億美元，預計2033年將達到95.9億美元。預計從2026年到2033年，該市場將以7.8%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	56.7億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	7.80%	2033年市場規模預測：	95.9億美元

勃起功能障礙是指在性交過程中無法維持足夠的勃起。這可能是生理或心理疾病的徵兆。壓力、老齡化、憂鬱症、糖尿病、血壓問題或不健康的生活習慣都可能導致勃起功能障礙。目前有多種治療勃起功能障礙的方法，包括藥物、注射和外用乳膏。市場參與企業正致力於研發能在最短時間內產生有效療效的藥物。威而鋼是治療勃起功能障礙最常使用的藥物之一。許多公司正在努力獲得學名藥的監管批准，這推動了勃起功能障礙治療市場的成長。例如，2017年12月，生產高品質學名藥的製藥公司梯瓦製藥（Teva Pharmaceuticals）獲得了美國食品藥物管理局（FDA）對其學名藥的批准。此外，2018年10月，另一種伐地那學名藥藥也獲得了美國FDA的批准。伐地那非是一種稱為磷酸二酯酶 (PDE) 抑制劑的藥物，其作用機制是透過增加陰莖組織的血流量來促進勃起。

市場動態

市場參與者正致力於提供先進的勃起功能障礙治療方案，以期取得顯著療效。預計這將加速全球勃起功能障礙治療市場在預測期內的成長。例如，根據美國國家生物技術資訊中心 (NCBI) 於 2019 年 1 月 25 日發表的報導，除了陰莖人工替代物、真空輔助勃起裝置和尿道栓劑等先進療法外，幹細胞療法、外用陰莖人工替代物、富血小板血漿 (PRP) 療法和陰莖衝擊波療法等新型療法也可用於治療勃起功能障礙，這些發病率正在降低勃起功能障礙的發病率正在治療勃起功能障礙。

預計在預測期內，人們對勃起功能障礙的治療和管理意識的提高將加速全球勃起功能障礙治療市場的成長。例如，2021年2月12日是“性與生殖健康宣傳日”，旨在提高人們對性健康的認知。這項活動由加拿大政府發起，此後推廣至全球。鑑於全球勃起功能障礙盛行率不斷上升，該活動旨在教育社會和教育弱勢群體，並預防勃起功能障礙引發的嚴重問題。

該計畫由加拿大政府發起，此後已推廣至世界各地。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、區域前景以及主要參與者採取的競爭策略。
本研究根據以下參數對全球勃起功能障礙治療市場的主要參與者進行了分析：公司概況、財務表現、產品系列、企業發展區域、分銷策略、關鍵發展和策略以及未來計劃。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
這份「全球勃起功能障礙治療市場報告」旨在為該行業的各種相關人員提供服務，包括投資者、供應商、製造商、經銷商、新參與企業和金融分析師。
相關人員可以利用各種用於分析全球勃起功能障礙治療市場的策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

公司簡介
- Mangoceuticals, Inc.
- Futura Medical
- CURE Pharmaceutical Holding Corp
- Glenmark Pharmaceuticals Ltd
- Mylan Pharmaceuticals Inc
- Boston Scientific
- Cipla Ltd
- Pfizer Inc
- Coloplast CORP
- Eli Lily & Co
- Gust Inc
- Altera
- Promedon
- Dr. Reddys Laboratories Ltd
- Bayer Pharma AG
- Reflexonic LLC

第9章

參考
調查方法

簡介目錄

Product Code: CMI200

Erectile Dysfunction Treatment Market is estimated to be valued at USD 5.67 Bn in 2026 and is expected to reach USD 9.59 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 5.67 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.80%	2033 Value Projection:	USD 9.59 Bn

Erectile dysfunction is the inability to maintain a firm erection during sexual activity. It is a sign of a physical or psychological condition. Erectile dysfunction is caused by stress, age, depression, diabetes, Blood pressure issues or an unhealthy lifestyle. Various treatments are available for erectile dysfunction such as drugs, injections, and topical creams. Market players are indulged in research and development activities for developing drugs for effective results with minimum time consumption. Viagra is one of the most used drugs for erectile dysfunction. Many companies are engaged to receive approval from regulatory authorities for generic medicines which drives the growth of erectile dysfunction treatment market. For instance, in December 2017, Teva Pharmaceuticals which is pharmaceutical manufacturer of high quality generic medicines has received the U.S. Food and Drug Administration (U.S.FDA) approval of generic medicine for Viagra and another generic version of Vardenafil was approved by the U.S.FDA in October 2018.Vardenafill is class of medicine called Phosphodiesterase (PDE) inhibitors which helps in increasing the blood flow to penile tissue to cause erection.

Market Dynamics

Market players are engaged in providing advanced treatments for erectile dysfunction for effective and efficient results. This is expected to increase the growth of the global erectile dysfunction treatment market over the forecast period. For instance, an article published on January 25, 2019 by the National Center for Biotechnology Information (NCBI) states that advanced treatments are available for erectile dysfunction treatment such as penile prosthesis, vacuum-assisted erectile, intraurethral suppository, along with novel therapies such as stem cell therapy, external penile prosthesis, platelet-rich plasma, and penile shockwave therapy, which help to reduce erectile dysfunction in men.

Increasing awareness for the treatment as well as management of erectile dysfunction is expected to increase the growth of the global erectile dysfunction treatment market over the forecast period. For instance, on February 12, 2021, Sexual and Reproductive Health Awareness day was celebrated to raise the awareness for sexual health awareness. This program was started by Canadian government, and it has since spread around the globe. This program aims to provide information to socially and educationally backward population to avoid the serious issues cause due to erectile dysfunction as the prevalence of erectile dysfunction is increasing globally.

This programme was started by the Canadian government, and it has since spread around the world.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global erectile dysfunction treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Boston Scientific, Mylan Pharmaceuticals Inc., Cipla Ltd., Pfizer Inc, Coloplast CORP, Eli Lily & Co, Gust Inc., Altera, Promedon , Dr. Reddys Laboratories Ltd., Zephyr Surgical Implants, Pos-T-Vac Inc., Bayer Pharma AG, Reflexonic Llc., Dong-A Pharmaceutical Co. Ltd., Owen Mumford Ltd., Vacurect Manufacturing Ltd., and
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global erectile dysfunction treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global erectile dysfunction treatment market

Detailed Segmentation:

Global Erectile Dysfunction Treatment Market, By Drugs (Revenue, USD Bn, 2021 - 2033)
Sildenafil (Viagra)
Vardenafil (Levitra Staxyn)
Tadalafil (Cialis)
Avanafil (Stendra)
Udenafil (Zydena)
Others
Global Erectile Dysfunction Treatment Market, By Route of Administration (Revenue, USD Bn, 2021 - 2033)
Oral drugs
Injections
Topical application
Global Erectile Dysfunction Treatment Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
Hospitals Pharmacies
Offline Pharmacies
Online Pharmacies
Global Erectile Dysfunction Treatment Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- By Drugs:
  - Sildenafil (Viagra)
  - Vardenafil (Levitra Staxyn)
  - Tadalafil (Cialis)
  - Avanafil (Stendra)
  - Udenafil (Zydena)
  - Others
- By Route of Administration:
  - Oral drugs
  - Injections
  - Topical application
- By Distribution Channel:
  - Hospitals Pharmacies
  - Offline Pharmacies
  - Online Pharmacies
- By Country:
  - U.S.
  - Canada
Latin America
- By Drugs:
  - Sildenafil (Viagra)
  - Vardenafil (Levitra Staxyn)
  - Tadalafil (Cialis)
  - Avanafil (Stendra)
  - Udenafil (Zydena)
  - Others
- By Route of Administration:
  - Oral drugs
  - Injections
  - Topical application
- By Distribution Channel:
  - Hospitals Pharmacies
  - Offline Pharmacies
  - Online Pharmacies
- By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- By Drugs:
  - Sildenafil (Viagra)
  - Vardenafil (Levitra Staxyn)
  - Tadalafil (Cialis)
  - Avanafil (Stendra)
  - Udenafil (Zydena)
  - Others
- By Route of Administration:
  - Oral drugs
  - Injections
  - Topical application
- By Distribution Channel:
  - Hospitals Pharmacies
  - Offline Pharmacies
  - Online Pharmacies
- By Country:
  - U.K.
  - Germany
  - Italy
  - Spain
  - France
  - Russia
  - Rest of Europe
Asia Pacific
- By Drugs:
  - Sildenafil (Viagra)
  - Vardenafil (Levitra Staxyn)
  - Tadalafil (Cialis)
  - Avanafil (Stendra)
  - Udenafil (Zydena)
  - Others
- By Route of Administration:
  - Oral drugs
  - Injections
  - Topical application
- By Distribution Channel:
  - Hospitals Pharmacies
  - Offline Pharmacies
  - Online Pharmacies
- By Country:
  - Australia
  - India
  - China
  - Japan
  - ASEAN
  - South Korea
  - Rest of Asia Pacific
Middle East
- By Drugs:
  - Sildenafil (Viagra)
  - Vardenafil (Levitra Staxyn)
  - Tadalafil (Cialis)
  - Avanafil (Stendra)
  - Udenafil (Zydena)
  - Others
- By Route of Administration:
  - Oral drugs
  - Injections
  - Topical application
- By Distribution Channel:
  - Hospitals Pharmacies
  - Offline Pharmacies
  - Online Pharmacies
- By Country:
  - GCC
  - Israel
  - Rest of Middle East
Africa
- By Drugs:
  - Sildenafil (Viagra)
  - Vardenafil (Levitra Staxyn)
  - Tadalafil (Cialis)
  - Avanafil (Stendra)
  - Udenafil (Zydena)
  - Others
- By Route of Administration:
  - Oral drugs
  - Injections
  - Topical application
- By Distribution Channel:
  - Hospitals Pharmacies
  - Offline Pharmacies
  - Online Pharmacies
- By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
Boston Scientific *
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
Mylan Pharmaceuticals Inc.
Cipla Ltd
Pfizer Inc.
Coloplast CORP
Eli Lily & Co,
Gust Inc.
Altera
Promedon
Reddys Laboratories Ltd
Zephyr Surgical Implants
Pos-T-Vac Inc.
Bayer Pharma AG
Reflexonic Llc.
Dong-A Pharmaceutical Co. Ltd.
Owen Mumford Ltd
Vacurect Manufacturing Ltd
Silimed

"*" marked represents similar segmentation in other categories in the respective section

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drugs
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Erectile Dysfunction Treatment Market, By Drugs, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Sildenafil (Viagra)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Vardenafil (Levitra Staxyn)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Tadalafil (Cialis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Avanafil (Stendra)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Udenafil (Zydena)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends

5. Global Erectile Dysfunction Treatment Market, By Route of Administration, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oral Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Topical Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends

6. Global Erectile Dysfunction Treatment Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

7. Global Erectile Dysfunction Treatment Market, By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Mangoceuticals, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Futura Medical
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- CURE Pharmaceutical Holding Corp
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Glenmark Pharmaceuticals Ltd
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Mylan Pharmaceuticals Inc
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Boston Scientific
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Cipla Ltd
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Pfizer Inc
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Coloplast CORP
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Eli Lily & Co
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Gust Inc
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Altera
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Promedon
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Dr. Reddys Laboratories Ltd
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Bayer Pharma AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Reflexonic LLC
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies